Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Tecogen Inc (AMEX: TGEN) was $8.33 for the day, down -3.48% from the previous closing price of $8.63. In other words, the price has decreased by -$3.48 from its previous closing price. On the day, 0.55 million shares were traded. TGEN stock price reached its highest trading level at $8.93 during the session, while it also had its lowest trading level at $8.01.
Ratios:
Our analysis of TGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Roth Capital on August 18, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Lafaille Stephen bought 400 shares for $2.50 per share. The transaction valued at 1,000 led to the insider holds 400 shares of the business.
Lafaille Stephen sold 25,000 shares of TGEN for $149,500 on Jun 06 ’25. The VP of Business Development now owns 400 shares after completing the transaction at $5.98 per share. On Jun 04 ’25, another insider, Lafaille Stephen, who serves as the VP of Business Development of the company, sold 15,000 shares for $5.00 each. As a result, the insider received 75,000 and left with 400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGEN now has a Market Capitalization of 247324368 and an Enterprise Value of 249219856. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.41 while its Price-to-Book (P/B) ratio in mrq is 23.41. Its current Enterprise Value per Revenue stands at 9.484 whereas that against EBITDA is -79.273.
Stock Price History:
The Beta on a monthly basis for TGEN is 1.07, which has changed by 7.009615 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, TGEN has reached a high of $11.55, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 4.70%, while the 200-Day Moving Average is calculated to be 115.87%.
Shares Statistics:
TGEN traded an average of 815.37K shares per day over the past three months and 1007080 shares per day over the past ten days. A total of 25.57M shares are outstanding, with a floating share count of 17.08M. Insiders hold about 42.46% of the company’s shares, while institutions hold 13.02% stake in the company. Shares short for TGEN as of 1753920000 were 985909 with a Short Ratio of 1.21, compared to 1751241600 on 692955. Therefore, it implies a Short% of Shares Outstanding of 985909 and a Short% of Float of 4.6899999999999995.
Earnings Estimates
Analysts are recommending an EPS of between -$0.17 and -$0.17 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.05, with 1 analysts recommending between -$0.05 and -$0.05.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $42.78M in the next fiscal year. The high estimate is $42.78M and the low estimate is $42.78M.
